Defining Hirsutism in Chinese Women: A Cross-Sectional Study

    July 2011 in “ Fertility and Sterility ”
    Xiaomiao Zhao, Renmin Ni, Li Lin, Yujun Mo, Jia Huang, Mei-Feng Huang, Ricardo Azziz, Dongzi Yang
    Image of study
    TLDR An mFG score of 5 or more indicates above-normal hair growth in Southern Chinese women.
    In a cross-sectional study of 2,988 Chinese women aged 20-45, a modified Ferriman-Gallwey (mFG) score of ≥5 was determined to be the cut-off for hirsutism, present in 10% of participants. This threshold was associated with higher incidences of acne, menstrual irregularities, polycystic ovaries, and acanthosis nigricans. The prevalence of hirsutism decreased with age, and a higher body mass index was correlated with increased mFG scores. The study's large sample size and use of cluster analysis to determine the cut-off score strengthened its findings, suggesting that an mFG score of 5 or greater indicates above-normal hair growth in Southern Chinese women.
    Discuss this study in the Community →

    Research cited in this study

    8 / 8 results

    Related Community Posts Join

    6 / 25 results

      community AA and Hirsutism but T levels are normal

      in Female  8 upvotes 3 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community Finasteride 5mg & Spironolactone 100mg

      in Female  2 upvotes 3 weeks ago
      A 20-year-old female is using finasteride 5mg and spironolactone 100mg for severe hirsutism and is experiencing minor side effects like water weight loss and irregular periods. She is concerned about potential future side effects and hair regrowth on her scalp.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  105 upvotes 3 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  118 upvotes 3 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Does low HGH leading to hairloss?

      in Research/Science  12 upvotes 10 months ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

    Related Research

    6 / 6 results